These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17786351

  • 1. Reduced expression of TANGO in colon and hepatocellular carcinomas.
    Arndt S, Bosserhoff AK.
    Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
    [Abstract] [Full Text] [Related]

  • 2. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
    Hellerbrand C, Bumes E, Bataille F, Dietmaier W, Massoumi R, Bosserhoff AK.
    Carcinogenesis; 2007 Jan; 28(1):21-7. PubMed ID: 16774947
    [Abstract] [Full Text] [Related]

  • 3. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP, Zhou HJ, Chen XP, Ren GY, Ruan XX, Zhang Y, Zhang RL, Chen J.
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [Abstract] [Full Text] [Related]

  • 4. TANGO is a tumor suppressor of malignant melanoma.
    Arndt S, Bosserhoff AK.
    Int J Cancer; 2006 Dec 15; 119(12):2812-20. PubMed ID: 17044017
    [Abstract] [Full Text] [Related]

  • 5. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
    Li WW, Wu WZ, Liang Y, Xiao CL, Tao ZH, Wang L, Sun HC, Fan J.
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan 15; 18(1):27-31. PubMed ID: 20128965
    [Abstract] [Full Text] [Related]

  • 6. Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes.
    Arndt S, Melle C, Mondal K, Klein G, von Eggeling F, Bosserhoff AK.
    J Leukoc Biol; 2007 Dec 15; 82(6):1466-72. PubMed ID: 17726152
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma.
    Chen RN, Huang YH, Yeh CT, Liao CH, Lin KH.
    Cancer Res; 2008 Mar 15; 68(6):1697-706. PubMed ID: 18339849
    [Abstract] [Full Text] [Related]

  • 8. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
    Hellerbrand C, Mühlbauer M, Wallner S, Schuierer M, Behrmann I, Bataille F, Weiss T, Schölmerich J, Bosserhoff AK.
    Carcinogenesis; 2006 Jan 15; 27(1):64-72. PubMed ID: 16081515
    [Abstract] [Full Text] [Related]

  • 9. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
    Liu W, Liu Y, Zhu J, Wright E, Ding I, Rodgers GP.
    Clin Cancer Res; 2008 Feb 15; 14(4):1041-9. PubMed ID: 18281536
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma.
    Barnard GF, Staniunas RJ, Bao S, Mafune K, Steele GD, Gollan JL, Chen LB.
    Cancer Res; 1992 Jun 01; 52(11):3067-72. PubMed ID: 1350508
    [Abstract] [Full Text] [Related]

  • 11. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target.
    Ito H, Funahashi S, Yamauchi N, Shibahara J, Midorikawa Y, Kawai S, Kinoshita Y, Watanabe A, Hippo Y, Ohtomo T, Iwanari H, Nakajima A, Makuuchi M, Fukayama M, Hirata Y, Hamakubo T, Kodama T, Tsuchiya M, Aburatani H.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3257-64. PubMed ID: 16740745
    [Abstract] [Full Text] [Related]

  • 12. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.
    J Pathol; 2009 Aug 01; 218(4):520-9. PubMed ID: 19431154
    [Abstract] [Full Text] [Related]

  • 13. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H.
    Cancer Res; 2007 Apr 15; 67(8):3574-82. PubMed ID: 17440068
    [Abstract] [Full Text] [Related]

  • 14. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G, Zhang SJ, Zhao YF, Wu Y, Li Z, Wang JX.
    Zhonghua Wai Ke Za Zhi; 2007 Apr 01; 45(7):499-502. PubMed ID: 17686315
    [Abstract] [Full Text] [Related]

  • 15. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
    Tomizawa M, Watanabe K, Saisho H, Nakagawara A, Tagawa M.
    Anticancer Res; 2003 Apr 01; 23(1A):351-4. PubMed ID: 12680236
    [Abstract] [Full Text] [Related]

  • 16. ING1a and ING1b different expressed in sporadic hepatocellular carcinoma.
    Chen X, Du J, Zhu T.
    Pathol Biol (Paris); 2009 May 01; 57(3):e17-21. PubMed ID: 18450387
    [Abstract] [Full Text] [Related]

  • 17. Association of NET-1 gene expression with human hepatocellular carcinoma.
    Chen L, Wang Z, Zhan X, Li DC, Zhu YY, Zhu J.
    Int J Surg Pathol; 2007 Oct 01; 15(4):346-53. PubMed ID: 17913940
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma.
    Kim CJ, Song JH, Cho YG, Cao Z, Lee YS, Nam SW, Lee JY, Park WS.
    Histopathology; 2008 Apr 01; 52(5):552-9. PubMed ID: 18312352
    [Abstract] [Full Text] [Related]

  • 19. Expression of Hugl-1 is strongly reduced in malignant melanoma.
    Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK.
    Oncogene; 2006 Jan 05; 25(1):103-10. PubMed ID: 16170365
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin CY, Chen DS, Chen PJ.
    Gastroenterology; 2009 Feb 05; 136(2):683-93. PubMed ID: 19027010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.